Arcus Biosciences Stock Quote RCUS - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

16.29

Bid

Ask

Volume

0.00 Day's Range 0.00

12.95 52 Week Range 25.47

Market Cap

1.481B

Previous Close

16.29

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

844,819

Shares Outstanding

90,864,829

Dividend Yield

PE Ratio

-4.82

Earnings Per Share (EPS)

-3.38

Revenue

117M

Net Profit

-307M

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule... Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB680, and Zimberelimab. Arcus conducts clinical trials for different types of cancers such as Prostate, Lung, Colorectal, Pancreatic, and others. The company operates through the single segment being the business of developing and commercializing immunotherapies. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.arcusbio.com

Headquarters

Camden, Delaware, USA

Founded

1970

Arcus Biosciences Inc is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker RCUS. The last closing price for Arcus Biosciences was $16.29. Over the last year, Arcus Biosciences shares have traded in a share price range of $ 12.95 to $ 25.47.

Arcus Biosciences currently has 90,864,829 shares outstanding. The market capitalization of Arcus Biosciences is $1.48 billion. Arcus Biosciences has a price to earnings ratio (PE ratio) of -4.82.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.75	-4.4014084507	17.04	17.64	16.03	461366	16.86176845	CS
4	-0.87	-5.06993006993	17.16	19.11	16.03	585880	17.35993759	CS
12	0.88	5.71057754705	15.41	20.31	14.62	844819	17.37592871	CS
26	0.17	1.05459057072	16.12	20.31	12.95	807149	16.8608179	CS
52	-1.38	-7.80984719864	17.67	25.47	12.95	880413	18.46097897	CS
156	-18.56	-53.2568149211	34.85	49.1	12.95	852441	24.53844533	CS
260	3.66	28.9786223278	12.63	49.1	6.3	679602	24.26293332	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
KAVLKaival Brands Innovations Group Inc	$ 6.26 (134.46%)	44.34M
LGVNLongeveron Inc	$ 2.94 (73.96%)	57.1M
HUBCHub Cyber Security Ltd	$ 1.9499 (49.99%)	75.08M
SPCBSuperCom Ltd	$ 0.40 (44.93%)	127.58M
ONVOOrganovo Holdings Inc	$ 1.345 (33.16%)	53.79M
MRNSMarinus Pharmaceuticals Inc	$ 1.29 (-82.85%)	35.57M
NXTPNextPlay Technologies Inc	$ 0.20 (-56.52%)	30.41k
CSLRComplete Solaria Inc	$ 0.26 (-50.00%)	814.26k
SWVLSwvl Holdings Corporation	$ 8.10 (-38.96%)	312.72k
MOTSMotus GI Holdings Inc	$ 0.173 (-34.25%)	1.37M
SQQQProShares UltraPro Short QQQ	$ 11.445 (5.10%)	201.04M
SNGXSoligenix Inc	$ 0.4697 (21.65%)	134.5M
SPCBSuperCom Ltd	$ 0.40 (44.93%)	127.58M
NKLANikola Corporation	$ 0.6503 (-7.14%)	121.2M
JAGXJaguar Health Inc	$ 0.109 (20.71%)	115.11M